Vesedaganat: vizsgálatok itt: Kína
92 of 117 trials · From ClinicalTrials.gov, checked 2026. november 18.. Ask the study team whether a trial fits you.
- 2. fázisTaking peopleA Study of Multimodal Radiotherapy for Renal Cell Carcinoma Progressed After Prior Immunotherapy
- Where
- Nanjing
- Életkor
- 18 év to 80 év
- People
- 35
- Run by
- Jinling Hospital, China
See details and how to joinNCT06255223 - Korai 1. fázisTaking people68Ga- and 18F-CAIX PET Imaging Study
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100
- Run by
- Peking University First Hospital
See details and how to joinNCT07875946 - 1/2. fázisNot yet taking people in KínaPhase Ib/II Clinical Study of QLS5133 Combination Therapy in Advanced Solid Tumors
- Where
- Jinan
- Életkor
- 18 év and over
- People
- 558
- Run by
- Qilu Pharmaceutical Co., Ltd.
See details and how to joinNCT07933419 - 2. fázisTaking peopleA Study of IBR854 Combined With Pazopanib Versus Pazopanib in Advanced Renal Cell Carcinoma
- Where
- Shanghai
- Életkor
- 18 év and over
- People
- 30
- Run by
- Imbioray (Hangzhou) Biomedicine Co., Ltd.
See details and how to joinNCT07087158 - 2. fázisTaking peopleProspective Study of Cadonilimab With Lenvatinib in Renal Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 54
- Run by
- Cancer Institute and Hospital, Chinese Academy of Medical Sciences
See details and how to joinNCT07909265 - 1/2. fázisNot yet taking people in KínaA Study to Evaluate the Safety, Tolerability, and Efficacy of Pumitamig Alone or in Combination With Other Agents in Participants With Advanced Renal Cell Carcinoma (RCC) (ROSETTA RCC-208)
- Where
- Beijing, Changsha Shi, Guangzhou, Harbin, Nanjing, Shanghai Shi, Tianjin
- Életkor
- 18 év and over
- People
- 474 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT07293351 · EU 2026-527163-15-00 - 2. fázisTaking peopleAn Exploratory Study on the Failure of Immunotherapy With Vorolanib Combined With Everolimus
- Where
- Guangzhou, Zhengzhou
- Életkor
- 18 év and over
- People
- 80
- Run by
- Sun Yat-sen University
See details and how to joinNCT06730672 - No phaseTaking peopleEffect of Non-Clamping and Sutureless Technique on Postoperative Renal Function in Robot-Assisted Partial Nephrectomy
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 304
- Run by
- Shao Pengfei
See details and how to joinNCT07888608 - 2. fázisNot yet taking people in KínaA Clinical Study of Ivonescimab in Combination With Cadonilimab or Ipilimumab for Advanced Renal Cancer
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 100 worldwide
- Run by
- Summit Therapeutics
See details and how to joinNCT07877194 - 2. fázisTaking peoplePerioperative Ursodeoxycholic Acid for Renal Protection in Adults Undergoing Partial Nephrectomy for Renal Tumors
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 162
- Run by
- Jinling Hospital, China
See details and how to joinNCT07672860 - No phaseTaking people18F-N230A PET/CT Imaging of Nectin-4 Expression in Renal Tumors
- Where
- Beijing
- Életkor
- 18 év and over
- People
- 80
- Run by
- Peking University First Hospital
See details and how to joinNCT07875959 - 1. fázisTaking peopleClinical Study of HS-IT101 Injection in the Treatment of Advanced Renal Cancer(FASTIL-Renal01)
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 15
- Run by
- Hangzhou Huasai Biomedicine Co., Ltd.
See details and how to joinNCT07770802 - No phaseTaking peopleCAIX-targeted PET/CT in Solid Tumors
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 100
- Run by
- Zhongnan Hospital
See details and how to joinNCT07833085 - 1/2. fázisTaking peopleSymbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- Where
- Beijing, Changsha, Chongqing, Jinan, Nanjing, Ningbo, Wuhan
- Életkor
- 18 év and over
- People
- 224 worldwide
- Run by
- Pfizer
See details and how to joinNCT07227415 · EU 2025-523524-53-00 - Korai 1. fázisNot yet taking people in KínaA Study of CA9-Targeted CAR Macrophage Therapy in Advanced Clear Cell Renal Cell Carcinoma
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 6
- Run by
- Liangyou Gu
See details and how to joinNCT07865832 - 2. fázisNot yet taking people in KínaSBRT Plus Anlotinib and Bimepolizumab in Locally Advanced or Metastatic Renal Cell Carcinoma
- Where
- Fuzhou
- Életkor
- 18 év to 80 év
- People
- 27
- Run by
- Fujian Cancer Hospital
See details and how to joinNCT07470840 - No phaseTaking peopleQLESP Block for Pain Control in Robotic Partial Nephrectomy
- Where
- Wuhan
- Életkor
- 18 év to 80 év
- People
- 120
- Run by
- Huazhong University of Science and Technology
See details and how to joinNCT07704970 - 1. fázisTaking peopleA First-in-Human Study of HH160 in Participants With Advanced or Metastatic Solid Tumors
- Where
- Jinan
- Életkor
- 18 év to 75 év
- People
- 299 worldwide
- Run by
- Huahui Health
See details and how to joinNCT07623369 - 1. fázisTaking peopleA Phase I Study of SIM0505 in Participants With Advanced Solid Tumors
- Where
- Beijing, Changsha, Guangzhou, Jinan, Jining, Shanghai, Shenyang, Shijiazhuang
- Életkor
- 18 év and over
- People
- 738 worldwide
- Run by
- NextCure, Inc.
See details and how to joinNCT06792552 - 1/2. fázisTaking peoplePhase Ib/II Clinical Study of SHR-8068 Combined Anti-tumor Drugs in the Treatment of Advanced Renal Cell Carcinom
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 92
- Run by
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
See details and how to joinNCT07239596 - 2. fázisTaking peopleCD70-Targeted Immuno-PET/CT-Directed Free of Therapy Used for mccRCC Patients With IMDC Favorable or Intermediate Risk
- Where
- Nanjing, Wuxi
- Életkor
- 18 év and over
- People
- 75
- Run by
- Jinling Hospital, China
See details and how to joinNCT07615348 - 2. fázisTaking peopleSABR Combined With Axitinib and Toripalimab for Oligometastatic Renal Cell Carcinoma
- Where
- Shijiazhuang
- Életkor
- 18 év and over
- People
- 48
- Run by
- Hebei Medical University Fourth Hospital
See details and how to joinNCT07744932 - 2. fázisNot yet taking people in KínaGut Microbiota Modulation for Immunotherapy Resensitization in Advanced Renal Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 90 év
- People
- 33
- Run by
- Jinling Hospital, China
See details and how to joinNCT07611825 - 2. fázisNot yet taking people in KínaA Prospective, Single-Arm, Multicenter Clinical Study of High-Risk Localized and Locally Advanced Renal Clear Cell Carcinoma
- Where
- Nanjing
- Életkor
- 18 év to 75 év
- People
- 54
- Run by
- The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
See details and how to joinNCT07741617 - 2. fázisNot yet taking people in KínaIpilimumab N01 Plus Sintilimab and Lenvatinib as First-line Therapy for Locally Advanced or Metastatic TFE3-Rearranged Renal Cell Carcinoma: A Prospective, Multicenter, Single-Arm, Phase II Clinical Trial
- Where
- Chengdu
- Életkor
- 14 év and over
- People
- 66
- Run by
- West China Hospital
See details and how to joinNCT07715565